A study to evaluate how well single and multiple doses of S072 are tolerated in healthy adult participants

2025-525039-15-01 Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 25 May 2026 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 64
Countries 1
Sites 1

Pain

Key facts

Sponsor
Sea4us Biotecnologia E Recursos Marinhos S.A.
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Trial duration
25 May 2026 → ongoing
Decision date (initial)
2026-04-16
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Pain

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Sea4us Biotecnologia E Recursos Marinhos S.A.

Sponsor organisation
Sea4us Biotecnologia E Recursos Marinhos S.A.
Address
Armazem 8, Porto Da Baleeira Sagres Porto Da Baleeira Sagres
City
Sagres
Postcode
8650-368
Country
Portugal

Scientific contact point

Organisation
Sea4us Biotecnologia E Recursos Marinhos S.A.
Contact name
Eduardo Moura

Public contact point

Organisation
Sea4us Biotecnologia E Recursos Marinhos S.A.
Contact name
Eduardo Moura

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ongoing, recruiting 64 1
Rest of world 0

Investigational sites

Spain

1 site · Ongoing, recruiting
Hospital Universitario La Paz
Clinical Pharmacology, Paseo De La Castellana 261, 28046, Madrid

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2026-05-25 2026-05-26

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2026-04-14 Spain Acceptable
2026-04-15
2026-04-16
2 NON SUBSTANTIAL MODIFICATION NSM-1 2026-05-22 Spain Acceptable
2026-04-15
2026-05-22
3 NON SUBSTANTIAL MODIFICATION NSM-2 2026-05-22 Spain Acceptable
2026-04-15
2026-05-22